XML 18 R7.htm IDEA: XBRL DOCUMENT v3.6.0.2
Corrections to Previously Issued Consolidated Financial Statements
6 Months Ended
Mar. 31, 2016
Corrections to Previously Issued Consolidated Financial Statements [Abstract]  
CORRECTIONS TO PREVIOUSLY ISSUED CONSOLIDATED FINANCIAL STATEMENTS

2. CORRECTIONS TO PREVIOUSLY ISSUED CONSOLIDATED FINANCIAL STATEMENTS

 

The Company discovered that it had erroneously stated that the research and development expenses were $0 and $0 for the three and six months ended March 31, 2016. Instead, our research and development expenses were $6,500,000 and $10,000,000 for the three and six months ended March 31, 2016.

 

The following tables present the effect of the correction discussed above and other adjustments on selected line items of our previously reported consolidated financial statements as of and for the period ended March 31, 2016.

 

    As of and for the Period Ended 
March 31, 2016
 
    Previously 
Reported
    Adjustments     Restated  
                   
Consolidated Statements of Balance Sheets                  
Due to related party     -       10,000,000       10,000,000  
Accumulated deficit     (425,749 )     (10,000,000 )     (10,425,749 )
                         

Consolidated Statements of Operations and Comprehensive Loss

                       
For the three months ended March 31, 2016                        
Research and development expenses     -       6,500,000       6,500,000  
Net Loss     (108,712 )     (6,500,000 )     (6,608,712 )
Basic and diluted loss per share     (0.00 )     (0.03 )     (0.03 )
For the six months ended March 31, 2016                        
Research and development expenses     -       10,000,000       10,000,000  
Net Loss     (110,1470       (10,000,000 )     (10,110,147 )
Basic and diluted loss per share     (0.00 )     (0.05 )     (0.05 )